Exosomal microRNAs in breast cancer and their potential in diagnosis, prognosis and treatment prediction

Faraji, G. (Ghazale); Moeini, P. (Pedram); Ranjbar, M.H. (Mohammad Hasan)

Authors:

Faraji, G. (Ghazale)

Moeini, P. (Pedram)

Ranjbar, M.H. (Mohammad Hasan)

Keywords:

Breast cancer
Diagnosis
Exosome
MicroRNA
Prognosis
Treatment

Issue Date:

2022

Publisher:

Elsevier

ISSN:

1618-0631

Note:

This is an open access article under the CC BY license

Citation:

Faraji, G. (Ghazale); Moeini, P. (Pedram); Ranjbar, M.H. (Mohammad Hasan). "Exosomal microRNAs in breast cancer and their potential in diagnosis, prognosis and treatment prediction". Pathology - Research and Practice. 238, 2022, 154081

Abstract

The significance of exosomal microRNAs (EmiRs) in breast cancer (BC) diagnosis has been widely addressed over the past decades. However, little information is still available regarding these reliable biomarkers’ impacts on BC early diagnosis, prognosis, and treatment outcome predictions, but their great potential in spotting BC early and their predictive essence in BC prognosis and treatment results are promising against this common cancer. The present review focuses on the most recent findings and advancements of EmiRs applications in BC early diagnosis and treatment prediction and identifies current helpful EmiRs that are widely used in this regard.

URI:

https://hdl.handle.net/10171/66147

DOI:

10.1016/j.prp.2022.154081

Appears in Collections:

DA - CIMA - Terapia génica - Terapia génica del cáncer - Artículos de revista

Files in This Item: